YD Bio Ltd: director Lu Shao-Ta exercised 3,135 shares

What happened

• Lu Shao-Ta, director, had 3,135 restricted share units (RSUs) vest and the filing shows a grant (A) of 3,135 RSUs, an exercise/conversion (M) acquiring 3,135 shares and an exercise/conversion (M) disposing 3,135 shares on Sep 30, 2026. The reported per-share price for the grant and the disposed conversion is $0.00; the filing notes an aggregate target grant date fair value of $60,000 for the Granted RSUs.

Key details

• Transaction date(s): Sep 30, 2026.
• Transaction codes and amounts: A (grant) 3,135 RSUs @ $0.00 (acquired); M (exercise/conversion) 3,135 shares (acquired) N/A; M (exercise/conversion) 3,135 shares (disposed) @ $0.00.
• Shares owned after the transaction: not specified in the filing.
• Relevant footnotes:
  • Each RSU represents a contingent right to one ordinary share.
  • The RSUs were granted under the YD Bio Limited Equity Incentive Plan with an aggregate target grant date fair value of $60,000 on Mar 31, 2026; vesting was scheduled in four equal quarterly installments beginning Mar 31, 2026 with the number of RSUs determined by dividing $15,000 by the seven trading-day VWAP ending on the trading day immediately prior to vesting.
  • The reporting person became entitled to a fixed number of RSUs on Sep 30, 2026 (the vesting date).
• Filing date: Oct 6, 2026; timeliness (whether the Form 4 was filed late) is not indicated in the filing.

Why it may matter

• The filing records derivative activity: RSUs vested and were converted/exercised into ordinary shares, and an equal number of shares were disposed per the Form 4 entries.
• The filing does not show why the insider traded or why the company acted.